|
National Stock Number(NSN): 6505-01-234-8934 (6505012348934, 012348934)
| NIIN: |
01-234-8934 |
Item Name: |
FAT EMULSION INJECTION |
INC: |
35184
|
| FSC: |
6505
|
Assignment Date: |
Jun-21-1986 |
CRIT: |
X |
IIG: |
35184 |
| ISC: |
5 |
Date Standardized: |
Jun-21-1986 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9270 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC49669-1310-05 |
66159
|
ALPHA THERAPEUTIC CORP |
H |
3 |
9 |
6 |
54 |
|
|
|
|
|
|
|
NDC49669-1310-05ALPHA THERAP CO |
88009
|
U S DEPT OF VETERANS AFFAIRS |
H |
3 |
2 |
|
|
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.210 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.20 PERCENTAGE, W/V EGG PHOSPHATIDES ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
PACKAGE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 MILLILITERS |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
WITH INTRAVENOUS INJECTION SET |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|